Chris Lau
All posts from Chris Lau
Chris Lau in Value Stocks,

Weekend Research for the Week Ahead: Watch Valeant Pharmaceuticals

Busy week ahead.

In biotech, Mylan - MYL - and Horizon Pharma HZNP - kick off the week.

Valeant Pharma - VRX - reports. Any earnings or revenue beat will send the stock back to $15/share.

Synergy Pharma - SGYP - needs better script numbers to give the stock a permanent boost.

Endo International - ENDP - a generic giant, reports at the end of the month.

Elsewhere, expet good news from Etsy and Take-Two - TTWO. Snap Inc. reports after tuesday’s close.

Snap will not likely beat consensus but FB, TWTR both reported a good quarter. Chances are low that SNAP will miss its lower outlook:


On Thursday, Nvidia - NVDA - needs a blowout quarter to justify the $205+ share price.

Himax Technologies - HIMX - will surely report good progress for its capex spend. analysts are against HIMX stock.